The Food and Drug Administration granted 19 spine-related device clearances in December.
Author: Staff
DePuy Synthes Spine has collaborated with DePuy Synthes Biomaterials to launch the CONFORM SHEET, a demineralized cancellous bone matrix for posterolateral spinal fusion surgery.
San Jose, Calif.-based SI-BONE announced its iFuse Implant System has been used in 10,000 procedures worldwide with more than 29,000 iFuse implants in place.
InVivo Therapeutics received conditional approval from the U.S. Food and Drug Administration to make changes in the protocol of its degradable polymer scaffold clinical trial, according to a Mass Device report.
The global minimally invasive surgery market is expected to reach a market value of $50.6 billion by 2019, according to a Transparency Market Research report.
In a Healthcare Finance News report, Jackie Griffin, associate vice president in client services at TriZetto Provider Solutions, discusses steps to take to kick-start ICD-10 planning at a medical practice.
Dallas-based North American Spine announced that its employees collected 1,304 pairs of new shoes to donate to Buckner International.
The management of obesity may help prevent new-onset sciatica, according to a Japanese study published in Spine.
New Britain-based The Hospital of Central Connecticut announced the addition of Leigh S. Brezenoff, MD, and Douglas Wisch, MD, to its medical staff, according to a New Britain Herald report.
James Andrews, MD, orthopedic surgeon and co-founder of the Andrews Institute in Gulf Breeze, Fla., performed arthroscopic knee surgery on the New York Giants wide receiver Victor Cruz.
